These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 32417076)

  • 1. Reinterpretation of Chromosomal Microarrays with Detailed Medical History.
    Farooqi MS; Figueroa S; Gotway G; Wang J; Luu HS; Park JY
    J Pediatr; 2020 Jul; 222():180-185.e1. PubMed ID: 32417076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Study on the Retrospective Reinterpretation of BRCA1 and BRCA2 Variants.
    Kim JJ; Kim DJ; Nam EJ; Song KE; Ham JY; Kim YK; Lee NY
    Clin Lab; 2024 Apr; 70(4):. PubMed ID: 38623660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromosomal Microarray Analysis as a First-Tier Clinical Diagnostic Test in Patients With Developmental Delay/Intellectual Disability, Autism Spectrum Disorders, and Multiple Congenital Anomalies: A Prospective Multicenter Study in Korea.
    Jang W; Kim Y; Han E; Park J; Chae H; Kwon A; Choi H; Kim J; Son JO; Lee SJ; Hong BY; Jang DH; Han JY; Lee JH; Kim SY; Lee IG; Sung IK; Moon Y; Kim M; Park JH
    Ann Lab Med; 2019 May; 39(3):299-310. PubMed ID: 30623622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Utility of Reinterpreting Previously Reported Genomic Epilepsy Test Results for Pediatric Patients.
    SoRelle JA; Thodeson DM; Arnold S; Gotway G; Park JY
    JAMA Pediatr; 2019 Jan; 173(1):e182302. PubMed ID: 30398534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reclassification of Variants of Uncertain Significance in Children with Inherited Arrhythmia Syndromes is Predicted by Clinical Factors.
    Bennett JS; Bernhardt M; McBride KL; Reshmi SC; Zmuda E; Kertesz NJ; Garg V; Fitzgerald-Butt S; Kamp AN
    Pediatr Cardiol; 2019 Dec; 40(8):1679-1687. PubMed ID: 31535183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variant classification changes over time in the clinical molecular diagnostic laboratory setting.
    Hahn E; Mighton C; Fisher Y; Wong A; Di Gioacchino V; Watkins N; Mayers J; Bombard Y; Charames GS; Lerner-Ellis J
    J Med Genet; 2024 Jul; 61(8):788-793. PubMed ID: 38806232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical utility of periodic reinterpretation of CNVs of uncertain significance: an 8-year retrospective study.
    Ravel JM; Renaud M; Muller J; Becker A; Renard É; Remen T; Lefort G; Dexheimer M; Jonveaux P; Leheup B; Bonnet C; Lambert L
    Genome Med; 2023 May; 15(1):39. PubMed ID: 37221613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Retrospective Review of Reclassification of Variants of Uncertain Significance in a Pediatric Epilepsy Cohort Undergoing Genetic Panel Testing.
    Chourasia N; Vaidya R; Sengupta S; Mefford HC; Wheless J
    Pediatr Neurol; 2024 Dec; 161():101-107. PubMed ID: 39357456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-pass whole genome sequencing as a cost-effective alternative to chromosomal microarray analysis for low- and middle-income countries.
    Mazzonetto PC; Villela D; Krepischi ACV; Pierry PM; Bonaldi A; Almeida LGD; Paula MG; Bürger MC; de Oliveira AG; Fonseca GGG; Giugliani R; Riegel-Giugliani M; Bertola D; Yamamoto GL; Passos-Bueno MR; Campos GDS; Machado ACD; Mazzeu JF; Perrone E; Zechi-Ceide RM; Kokitsu-Nakata NM; Vieira TP; Steiner CE; Gil-da-Silva-Lopes VL; Vieira DKR; Boy R; de Pina-Neto JM; Scapulatempo-Neto C; Milanezi F; Rosenberg C
    Am J Med Genet A; 2024 Nov; 194(11):e63802. PubMed ID: 38924610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Data sharing to improve concordance in variant interpretation across laboratories: results from the Canadian Open Genetics Repository.
    Mighton C; Smith AC; Mayers J; Tomaszewski R; Taylor S; Hume S; Agatep R; Spriggs E; Feilotter HE; Semenuk L; Wong H; Lazo de la Vega L; Marshall CR; Axford MM; Silver T; Charames GS; Di Gioacchino V; Watkins N; Foulkes WD; Clavier M; Hamel N; Chong G; Lamont RE; Parboosingh J; Karsan A; Bosdet I; Young SS; Tucker T; Akbari MR; Speevak MD; Vaags AK; Lebo MS; Lerner-Ellis J;
    J Med Genet; 2022 Jun; 59(6):571-578. PubMed ID: 33875564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multicenter study of clinical impact of variant of uncertain significance reclassification in breast, ovarian and colorectal cancer susceptibility genes.
    Makhnoon S; Levin B; Ensinger M; Mattie K; Volk RJ; Zhao Z; Mendoza T; Shete S; Samiian L; Grana G; Grainger A; Arun B; Shirts BH; Peterson SK
    Cancer Med; 2023 Feb; 12(3):2875-2884. PubMed ID: 36426404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Variant Reclassification in Cancer Predisposition Genes on Clinical Care.
    Chiang J; Chia TH; Yuen J; Shaw T; Li ST; Binte Ishak ND; Chew EL; Chong ST; Chan SH; Ngeow J
    JCO Precis Oncol; 2021 Nov; 5():577-584. PubMed ID: 34994607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prioritize Variant Reclassification in Pediatric Long QT Syndrome-Time to Revisit.
    Leung HT; Kwok SY; Kwong KY; Shih FY; Tsao S; Chung BH
    Pediatr Cardiol; 2024 Jun; 45(5):1023-1035. PubMed ID: 38565666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Management of Patients at Risk for Hereditary Breast Cancer with Variants of Uncertain Significance in the Era of Multigene Panel Testing.
    Chang J; Seng S; Yoo J; Equivel P; Lum SS
    Ann Surg Oncol; 2019 Oct; 26(10):3389-3396. PubMed ID: 31342386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reanalysis of eMERGE phase III sequence variants in 10,500 participants and infrastructure to support the automated return of knowledge updates.
    Zouk H; Yu W; Oza A; Hawley M; Vijay Kumar PK; Koch C; Mahanta LM; Harley JB; Jarvik GP; Karlson EW; Leppig KA; Myers MF; Prows CA; Williams MS; Weiss ST; Lebo MS; Rehm HL
    Genet Med; 2022 Feb; 24(2):454-462. PubMed ID: 34906510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variants of unknown significance on chromosomal microarray analysis: parental perspectives.
    Jez S; Martin M; South S; Vanzo R; Rothwell E
    J Community Genet; 2015 Oct; 6(4):343-9. PubMed ID: 25666435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multi-gene panel testing for hereditary cancer susceptibility in a rural Familial Cancer Program.
    Hermel DJ; McKinnon WC; Wood ME; Greenblatt MS
    Fam Cancer; 2017 Jan; 16(1):159-166. PubMed ID: 27401692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromosomal Microarray Analysis of Consecutive Individuals with Autism Spectrum Disorders Using an Ultra-High Resolution Chromosomal Microarray Optimized for Neurodevelopmental Disorders.
    Ho KS; Wassman ER; Baxter AL; Hensel CH; Martin MM; Prasad A; Twede H; Vanzo RJ; Butler MG
    Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27941670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ethnic disparities among men with prostate cancer undergoing germline testing.
    Kwon DH; Borno HT; Cheng HH; Zhou AY; Small EJ
    Urol Oncol; 2020 Mar; 38(3):80.e1-80.e7. PubMed ID: 31630993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding variants of uncertain significance in the era of multigene panels: Through the eyes of the patient.
    Reuter C; Chun N; Pariani M; Hanson-Kahn A
    J Genet Couns; 2019 Aug; 28(4):878-886. PubMed ID: 31050105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.